News Breaks |
|
|
| September 20, 2012 |
| 07:25 EDT |  | PLX, ROVI, ARRY, NGNM, SPPI, SMA, BMY, BRKR, ARNA, REGN | UBS to host a conference
Global Life Sciences Conference is being held in New York on September 19-20 with webcasted company presentations to begin on September 20 at 7:30 am; not all company presentations may be webcasted. Webcast Link |
|
|
News For ARNA;REGN;SPPI;ROVI;BMY;NGNM;PLX;SMA;ARRY;BRKR From The Last 14 Days Check below for free stories on ARNA;REGN;SPPI;ROVI;BMY;NGNM;PLX;SMA;ARRY;BRKR the last two weeks. |
|
|
| May 17, 2013 |
| 13:21 EDT |  | BMY | Options with increasing implied volatility: CPRT BMY GDI HNZ
 Subscribe for More Information |
|
| 11:53 EDT | | ARNA | Options with decreasing implied volatility: SGMO ARNA CSC ENDP
Subscribe for More Information |
|
| 10:07 EDT |  | REGN | On The Fly: Analyst Initiation Summary
Subscribe for More Information |
|
| 07:16 EDT | | REGN | Regeneron initiated with a Neutral at UBS
Subscribe for More Information |
|
| 06:33 EDT | | REGN | American Thoracic Society to hold a conference
Subscribe for More Information |
|
| May 16, 2013 |
| 16:32 EDT |  | BMY | Bristol-Myers announces intention to voluntarily delist preferred stock
Subscribe for More Information |
|
| 13:20 EDT |  | BMY | Follow-up: Bristol-Myers upgraded to Outperform from Market Perform at Leerink
Leerink upgraded Bristol-Myers citing the company's multi-billion dollar immuno-oncology prospects. The firm says there were additional responses reported in the press briefing with combination nivolumab and Yervoy. Leerink has a $51 price target for shares. |
|
| 13:14 EDT | | BMY | Bristol-Myers upgraded to Outperform from Market Perform at Leerink
Subscribe for More Information |
|
| 11:15 EDT | | PLX | High option volume stocks: HMY MOLX PLX DSW EGLE
Subscribe for More Information |
|
| 08:55 EDT | | BMY | BofA/Merrill's pharmaceuticals analysts hold analyst/industry conference call
Subscribe for More Information |
| |
| 08:38 EDT |  | BMY | Bristol-Myers shares likely to give back recent gains, says Leerink
Leerink expects shares of Bristol-Myers to give back recent gains after ASCO published abstracts last night. The firm found the abstracts as in-line with, but not above, its expectations for nivolumab alone or immuno-oncology combination therapy and keeps a Market Perform rating on Bristol-Myers. |
|
| 07:26 EDT | | ROVI | JPMorgan to host a conference
41st Annual Global Technology, Media & Telecom Conference is being held in Boston on May 14-16 with webcasted company presentations to begin on May 16 at 8 am; not all company presentations may be webcasted. Webcast Link |
|
| 05:52 EDT | | BMY | Stocks with implied volatility movement; BMY SLV
Subscribe for More Information |
|
| May 15, 2013 |
| 19:34 EDT | | SPPI | On The Fly: After Hours Movers
Subscribe for More Information |
|
| 14:03 EDT | | ARNA | Arena Pharma has positive read through from Eisai forecast, says Piper Jaffray
Subscribe for More Information |
|
| 11:28 EDT | | BMY | Options with increasing implied volatility: BMY AGNC EBIX IAU
Subscribe for More Information |
|
| 11:16 EDT | | SPPI | Options with decreasing implied volatility: RAX CSC SPPI MBI PANL
|
|
| 09:51 EDT | | ARRY | Array BioPharma management to meet with Leerink
Meeting to be held in San Francisco on May 17 hosted by Leerink. |
|
| 09:43 EDT | | BMY | Active equity option families trading on open
Subscribe for More Information |
|
| 06:19 EDT | | ARNA | Arena Pharmaceuticals implied volatility at lower end of index mean range
Subscribe for More Information |
| |
|
|
|
|
